Developer docs
API playgroundTry for free, no card

Search company profiles

East Sunshine

Full company profile

uuid003h1ee

Namestring
East Sunshine
Legal namestring
东阳光集团 (East Sunshine Group)
Websiteurl
hec.cn
Company typeenum
Private
Founded yearint
1997
Descriptiontext

East Sunshine Group is a privately held Chinese high-tech conglomerate founded in 1997 in Dongguan, Guangdong, operating across three industrial verticals: electronic new materials, biopharmaceuticals, and health and wellness. The group holds two publicly listed subsidiaries — Guangdong East Sunshine Technology Holdings (600673.SH on the Shanghai A-share market) and East Sunshine Pharmaceutical (06887.HK on the Hong Kong Stock Exchange) — and reports total assets exceeding 90 billion RMB, with cumulative taxes paid of more than 23 billion RMB since inception. Operations span seven domestic production bases (Dongguan, Shaoguan, Yichang, Dongyang, Ulanqab, Zunyi, and Linzhi) plus 15 overseas sales branches across Japan, the United States, Germany, Australia, the United Kingdom, South Korea, Indonesia, France, and India, with overseas markets contributing roughly 15% of total sales.

The group's technology foundation rests on its 2005-established research institute, which has grown to 1,700+ R&D personnel (including 100+ PhDs, 1,000+ Masters, and 20+ foreign experts) and 3,500+ patent applications (1,500+ international). Its most distinctive proprietary technology is industrial-scale ecological cultivation of Cordyceps sinensis — a globally first — supported by a ~400,000 square meter cultivation base yielding 60+ tons annually, two consumer brands ('East Sunshine Fresh Cordyceps' and 'East Sunshine Buzhi'), and a State Administration of Traditional Chinese Medicine key laboratory designation. The electronic materials business is currently being reorganized around a new core industrial chain spanning power components, new chemical materials, liquid cooling technology, and AI computing power infrastructure.

East Sunshine operates through five coordinated sales platforms staffed by 4,000+ dedicated sales personnel, targeting B2B enterprise customers in electronics and pharmaceuticals (hospitals, pharmacies, distributors, API manufacturers) and B2C consumers for cordyceps-based health products via Tmall and retail channels. Recent strategic actions — including the December 2025 acquisition of Suzhou Datu Thermal Control for high-power chip liquid cooling, the August 2025 acquisition of Yichang Changjiang Pharmaceutical, and the April 2026 groundbreaking of an advanced computing power industrial base with Qinhui Data — indicate active repositioning of the materials and pharmaceutical core toward AI-era infrastructure adjacencies.

Short descriptiontext

East Sunshine Group is a privately held Chinese high-tech conglomerate operating in electronic new materials, biopharmaceuticals, and cordyceps-based health products, with two listed subsidiaries (600673.SH and 06887.HK), seven domestic production bases, 30,000+ employees, and an expanding pivot toward AI computing infrastructure and liquid cooling technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersShenzhen, China
HQ citystring
Shenzhen
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices17 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electronic new materials, biopharmaceuticals manufacturing, cordyceps health supplements, liquid cooling technology, aluminum foil production
Industry2 codes
PRIMARYIMAEAAAC
Chlor-Alkali & Derivatives
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Mushroom Production111411
SIC code3 codes
  • Chemicals & Allied Products2800
  • Medicinal Chemicals & Botanical Products2833
  • Miscellaneous Chemical Products2890
Product category
Diversified Industrial Manufacturing (Electronic Materials, Pharmaceuticals, Health Products)
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1电子新材料 (Electronic New Materials)
TypeHardware Sales
Description

Manufacturing and sales of aluminum foil, electronic components, chemical new materials, and energy materials. Listed on A-share market as East Sunshine (600673.SH).

hec.cn:443
2生物医药 (Biopharmaceuticals)
TypeSubscription Recurring
Description

R&D, production and sales of pharmaceuticals. Listed on Hong Kong Stock Exchange as East Sunshine Pharma (06887.HK). Focus on infection, chronic disease, and oncology treatment areas.

hec.cn:443
3健康养生 (Health and Wellness)
TypeHardware Sales
Description

Cordyceps-based health products under two brands: premium 'East Sunshine Fresh Cordyceps' (东阳光鲜虫草) and mass-market 'East Sunshine Buzhi' (东阳光补己). Sold through Tmall e-commerce and retail channels.

hec.cn:443
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1东阳光鲜虫草 (East Sunshine Fresh Cordyceps)
Description

High-end cordyceps sinensis brand positioned as benchmark quality product for premium health supplements.

hec.cn:443
+3 more records
Core offering1 text field

East Sunshine Group manufactures and sells electronic new materials (aluminum foil, electronic components, chemical new materials, energy materials, and liquid cooling solutions for data centers and AI servers), develops and commercializes biopharmaceuticals for infection, chronic disease, and oncology treatment areas, and produces cordyceps-based health supplements under the East Sunshine Fresh Cordyceps (premium) and East Sunshine Buzhi (mass-market) brands. The group operates seven production bases across China and exports through 15 overseas branches, with total assets exceeding 90 billion RMB and over 30,000 employees.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Annual cordyceps production capacity exceeding 60 tons from 400,000+ sqm ecological cultivation base
+2 more records
Product overview1 text field

East Sunshine (东阳光) is a large-scale high-tech股份制 enterprise operating three main industry sectors: electronic new materials, biopharmaceuticals, and health/lifestyle products. The company has two listed entities - Dongyangguang (600673.SH) in electronic materials and Dongyangguang Pharmaceutical (01558.HK, 06887.HK) in pharmaceuticals - with seven production bases across China. In electronic materials, the company is transforming toward AI computing power and liquid cooling technology. In pharmaceuticals, it focuses on infectious diseases, chronic conditions, and oncology with integrated R&D, manufacturing, and sales. In health products, it operates the world's first large-scale cordyceps ecological cultivation with two consumer brands: premium 'Dongyangguang Fresh Cordyceps' and value-oriented 'Dongyangguang Buchi'.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1秦淮数据 (Qinhui Data)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-03
Description

East Sunshine and Qinhui Data jointly established the Advanced Computing Power Industry Base project in Yichang, Yidu City. The project represents East Sunshine's strategic entry into AI computing infrastructure, combining East Sunshine's industrial capabilities with Qinhui Data's data center expertise.

hec.cn:443
2大图热控 (Datu Thermal Control / Suzhou Datu Thermal Control Technology Co., Ltd.)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-05
Description

East Sunshine's liquid cooling subsidiary (Zhejiang East Sunshine Liquid Cooling Technology Co., Ltd.) completed acquisition framework agreement with the actual controller of Datu Thermal Control. Datu Thermal Control is an industry leader in high-power chip liquid cooling technology. This acquisition strengthens East Sunshine's strategic position in liquid cooling and high-performance heat dissipation for data centers and AI servers.

hec.cn:443
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Sino Biopharmaceutical
TypeDirect peer
Description

Hong Kong-listed Chinese pharmaceutical conglomerate with diversified therapeutic-area coverage and growing innovation pipeline. Comparable to East Sunshine Pharma in listed-pharma scale, R&D breadth, and therapeutic-area diversification.

2Jiangsu Hengrui Medicine
TypeDirect peer
Description

China's largest innovative pharmaceutical company, listed on Shanghai A-share, with strong R&D in oncology and chronic disease. Comparable to East Sunshine Pharma in pharmaceutical innovation pipeline and internationalization ambitions.

TypeDirect peer
Description

Diversified Chinese conglomerate with operations spanning pharmaceuticals (Fosun Pharma), health products, and industrial/consumer businesses. Comparable as a privately controlled group with multiple listed subsidiaries operating across unrelated verticals.

4Tongwei Co., Ltd.
TypeBroad incumbent
Description

Major Chinese electronic materials and energy materials manufacturer (silicon, solar, agriculture). Comparable to East Sunshine Technology in electronic new materials, chemicals, and energy materials manufacturing scale.

TypeBroad incumbent
Description

China's leading battery and energy materials company with adjacent electronic materials capabilities. Comparable to East Sunshine Technology's energy materials and chemical materials businesses in scale and advanced manufacturing.

TypeDirect peer
Description

Hong Kong-listed Chinese pharmaceutical company with strong oncology, chronic disease, and API operations. Comparable to East Sunshine Pharma in therapeutic focus, R&D investment, and internationalization strategy.

7Yunnan Baiyao Group
TypeDirect peer
Description

Chinese TCM and health-products conglomerate with proprietary botanical formulations and integrated manufacturing. Directly comparable to East Sunshine's cordyceps health-products business and pharmaceutical distribution platform.

8Shanghai Pharmaceuticals Holding
TypeBroad incumbent
Description

Dual-listed (Shanghai and Hong Kong) Chinese pharmaceutical distributor and manufacturer with both innovative drugs and API businesses. Comparable to East Sunshine Pharma in dual-exchange listing and integrated pharma distribution.

TypeRegional player
Description

China-based biopharmaceutical company focused on biological products including vaccines and biosimilars. Comparable to East Sunshine Pharma in biopharmaceutical R&D and Chinese-market commercialization.

10China Traditional Chinese Medicine Holdings
TypeDirect peer
Description

Hong Kong-listed TCM manufacturer and distributor focused on classic Chinese medicine formulations. Comparable to East Sunshine Pharma in TCM pharmaceutical R&D, manufacturing, and distribution.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

East Sunshine

Diversified Industrial Manufacturing (Electronic Materials, Pharmaceuticals, Health Products)hec.cn

East Sunshine Group is a privately held Chinese high-tech conglomerate operating in electronic new materials, biopharmaceuticals, and cordyceps-based health products, with two listed subsidiaries (600673.SH and 06887.HK), seven domestic production bases, 30,000+ employees, and an expanding pivot toward AI computing infrastructure and liquid cooling technology.

What East Sunshine does

East Sunshine Group is a privately held Chinese high-tech conglomerate founded in 1997 in Dongguan, Guangdong, operating across three industrial verticals: electronic new materials, biopharmaceuticals, and health and wellness. The group holds two publicly listed subsidiaries — Guangdong East Sunshine Technology Holdings (600673.SH on the Shanghai A-share market) and East Sunshine Pharmaceutical (06887.HK on the Hong Kong Stock Exchange) — and reports total assets exceeding 90 billion RMB, with cumulative taxes paid of more than 23 billion RMB since inception. Operations span seven domestic production bases (Dongguan, Shaoguan, Yichang, Dongyang, Ulanqab, Zunyi, and Linzhi) plus 15 overseas sales branches across Japan, the United States, Germany, Australia, the United Kingdom, South Korea, Indonesia, France, and India, with overseas markets contributing roughly 15% of total sales.

The group's technology foundation rests on its 2005-established research institute, which has grown to 1,700+ R&D personnel (including 100+ PhDs, 1,000+ Masters, and 20+ foreign experts) and 3,500+ patent applications (1,500+ international). Its most distinctive proprietary technology is industrial-scale ecological cultivation of Cordyceps sinensis — a globally first — supported by a ~400,000 square meter cultivation base yielding 60+ tons annually, two consumer brands ('East Sunshine Fresh Cordyceps' and 'East Sunshine Buzhi'), and a State Administration of Traditional Chinese Medicine key laboratory designation. The electronic materials business is currently being reorganized around a new core industrial chain spanning power components, new chemical materials, liquid cooling technology, and AI computing power infrastructure.

East Sunshine operates through five coordinated sales platforms staffed by 4,000+ dedicated sales personnel, targeting B2B enterprise customers in electronics and pharmaceuticals (hospitals, pharmacies, distributors, API manufacturers) and B2C consumers for cordyceps-based health products via Tmall and retail channels. Recent strategic actions — including the December 2025 acquisition of Suzhou Datu Thermal Control for high-power chip liquid cooling, the August 2025 acquisition of Yichang Changjiang Pharmaceutical, and the April 2026 groundbreaking of an advanced computing power industrial base with Qinhui Data — indicate active repositioning of the materials and pharmaceutical core toward AI-era infrastructure adjacencies.

East Sunshine firmographics

Firmographics
Name
East Sunshine
Legal name
东阳光集团 (East Sunshine Group)
Website
https://hec.cn
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
10,001+ employees
Short description
East Sunshine Group is a privately held Chinese high-tech conglomerate operating in electronic new materials, biopharmaceuticals, and cordyceps-based health products, with two listed subsidiaries (600673.SH and 06887.HK), seven domestic production bases, 30,000+ employees, and an expanding pivot toward AI computing infrastructure and liquid cooling technology.
Ownership category
akta.pro rank

East Sunshine industry classification

Industry
Product category
Diversified Industrial Manufacturing (Electronic Materials, Pharmaceuticals, Health Products)
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Mushroom Production (111411)
SIC
Chemicals & Allied Products (2800), Medicinal Chemicals & Botanical Products (2833), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAEAAAC
Chlor-Alkali & Derivatives
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)

Keywords

  • Electronic new materials
  • Biopharmaceuticals manufacturing
  • Cordyceps health supplements
  • Liquid cooling technology
  • Aluminum foil production

Where East Sunshine is headquartered

Location

Headquarters

HQ city
Shenzhen
HQ country
China
HQ region
Asia

Offices17 records

Markets served

East Sunshine business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. 电子新材料 (Electronic New Materials): Manufacturing and sales of aluminum foil, electronic components, chemical new materials, and energy materials. Listed on A-share market as East Sunshine (600673.SH).
  2. 生物医药 (Biopharmaceuticals): R&D, production and sales of pharmaceuticals. Listed on Hong Kong Stock Exchange as East Sunshine Pharma (06887.HK). Focus on infection, chronic disease, and oncology treatment areas.
  3. 健康养生 (Health and Wellness): Cordyceps-based health products under two brands: premium 'East Sunshine Fresh Cordyceps' (东阳光鲜虫草) and mass-market 'East Sunshine Buzhi' (东阳光补己). Sold through Tmall e-commerce and retail channels.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

East Sunshine product offering

Product offering

Core offering

East Sunshine Group manufactures and sells electronic new materials (aluminum foil, electronic components, chemical new materials, energy materials, and liquid cooling solutions for data centers and AI servers), develops and commercializes biopharmaceuticals for infection, chronic disease, and oncology treatment areas, and produces cordyceps-based health supplements under the East Sunshine Fresh Cordyceps (premium) and East Sunshine Buzhi (mass-market) brands. The group operates seven production bases across China and exports through 15 overseas branches, with total assets exceeding 90 billion RMB and over 30,000 employees.

Product overview

East Sunshine (东阳光) is a large-scale high-tech股份制 enterprise operating three main industry sectors: electronic new materials, biopharmaceuticals, and health/lifestyle products. The company has two listed entities - Dongyangguang (600673.SH) in electronic materials and Dongyangguang Pharmaceutical (01558.HK, 06887.HK) in pharmaceuticals - with seven production bases across China. In electronic materials, the company is transforming toward AI computing power and liquid cooling technology. In pharmaceuticals, it focuses on infectious diseases, chronic conditions, and oncology with integrated R&D, manufacturing, and sales. In health products, it operates the world's first large-scale cordyceps ecological cultivation with two consumer brands: premium 'Dongyangguang Fresh Cordyceps' and value-oriented 'Dongyangguang Buchi'.

Differentiator

Problem solved

Functional benefit

Brands

  • 东阳光鲜虫草 (East Sunshine Fresh Cordyceps): High-end cordyceps sinensis brand positioned as benchmark quality product for premium health supplements.
  • 东阳光补己 (East Sunshine Buji)
  • 东阳光药 (East Sunshine Pharmaceutical)
  • 东阳光科技 (East Sunshine Technology)

Quantifiable outcome

  • Annual cordyceps production capacity exceeding 60 tons from 400,000+ sqm ecological cultivation base
  • +2 more outcomes

Companies that use East Sunshine

Customer profile

Segments3 records

Ideal customer profiles3 records

East Sunshine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

East Sunshine partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • 秦淮数据 (Qinhui Data)coreStrategic or Co-development Partner · 3 April 2026East Sunshine and Qinhui Data jointly established the Advanced Computing Power Industry Base project in Yichang, Yidu City. The project represents East Sunshine's strategic entry into AI computing infrastructure, combining East Sunshine's industrial capabilities with Qinhui Data's data center expertise.
  • 大图热控 (Datu Thermal Control / Suzhou Datu Thermal Control Technology Co., Ltd.)coreStrategic or Co-development Partner · 5 December 2025East Sunshine's liquid cooling subsidiary (Zhejiang East Sunshine Liquid Cooling Technology Co., Ltd.) completed acquisition framework agreement with the actual controller of Datu Thermal Control. Datu Thermal Control is an industry leader in high-power chip liquid cooling technology. This acquisition strengthens East Sunshine's strategic position in liquid cooling and high-performance heat dissipation for data centers and AI servers.

Scale indicators13 records

Recent moves5 records

Expansion highlights5 records

East Sunshine competitors and assessment

Company assessment

Direct peers

  • Sino Biopharmaceutical: Hong Kong-listed Chinese pharmaceutical conglomerate with diversified therapeutic-area coverage and growing innovation pipeline. Comparable to East Sunshine Pharma in listed-pharma scale, R&D breadth, and therapeutic-area diversification.
  • Jiangsu Hengrui Medicine: China's largest innovative pharmaceutical company, listed on Shanghai A-share, with strong R&D in oncology and chronic disease. Comparable to East Sunshine Pharma in pharmaceutical innovation pipeline and internationalization ambitions.
  • Fosun International: Diversified Chinese conglomerate with operations spanning pharmaceuticals (Fosun Pharma), health products, and industrial/consumer businesses. Comparable as a privately controlled group with multiple listed subsidiaries operating across unrelated verticals.
  • CSPC Pharmaceutical Group: Hong Kong-listed Chinese pharmaceutical company with strong oncology, chronic disease, and API operations. Comparable to East Sunshine Pharma in therapeutic focus, R&D investment, and internationalization strategy.
  • Yunnan Baiyao Group: Chinese TCM and health-products conglomerate with proprietary botanical formulations and integrated manufacturing. Directly comparable to East Sunshine's cordyceps health-products business and pharmaceutical distribution platform.
  • China Traditional Chinese Medicine Holdings: Hong Kong-listed TCM manufacturer and distributor focused on classic Chinese medicine formulations. Comparable to East Sunshine Pharma in TCM pharmaceutical R&D, manufacturing, and distribution.

Broad incumbents

  • Tongwei Co., Ltd. Major Chinese electronic materials and energy materials manufacturer (silicon, solar, agriculture). Comparable to East Sunshine Technology in electronic new materials, chemicals, and energy materials manufacturing scale.
  • CATL (Contemporary Amperex Technology): China's leading battery and energy materials company with adjacent electronic materials capabilities. Comparable to East Sunshine Technology's energy materials and chemical materials businesses in scale and advanced manufacturing.
  • Shanghai Pharmaceuticals Holding: Dual-listed (Shanghai and Hong Kong) Chinese pharmaceutical distributor and manufacturer with both innovative drugs and API businesses. Comparable to East Sunshine Pharma in dual-exchange listing and integrated pharma distribution.

Regional players

  • Walvax Biotechnology: China-based biopharmaceutical company focused on biological products including vaccines and biosimilars. Comparable to East Sunshine Pharma in biopharmaceutical R&D and Chinese-market commercialization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

East Sunshine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

East Sunshine leadership team

Management profile

Number of profiles

Profiles1 record

East Sunshine subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

East Sunshine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

East Sunshine M&A and investment

M&A and investment

M&A1 record

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about East Sunshine

What does East Sunshine do?

East Sunshine Group manufactures and sells electronic new materials (aluminum foil, electronic components, chemical new materials, energy materials, and liquid cooling solutions for data centers and AI servers), develops and commercializes biopharmaceuticals for infection, chronic disease, and oncology treatment areas, and produces cordyceps-based health supplements under the East Sunshine Fresh Cordyceps (premium) and East Sunshine Buzhi (mass-market) brands. The group operates seven production bases across China and exports through 15 overseas branches, with total assets exceeding 90 billion RMB and over 30,000 employees.

Is East Sunshine a public or private company?

East Sunshine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was East Sunshine founded?

East Sunshine was founded in 1997. It employs 10,001+ people.

Where is East Sunshine based?

East Sunshine is headquartered in Shenzhen, China, in the Asia region.

How does East Sunshine make money?

Three revenue lines are on record. 电子新材料 (Electronic New Materials) is the primary driver. The others are 生物医药 (Biopharmaceuticals) and 健康养生 (Health and Wellness).

Who are East Sunshine's main competitors?

Direct peers on record are Sino Biopharmaceutical, Jiangsu Hengrui Medicine, Fosun International, CSPC Pharmaceutical Group, Yunnan Baiyao Group and China Traditional Chinese Medicine Holdings. Broad incumbents are Tongwei Co., Ltd., CATL (Contemporary Amperex Technology) and Shanghai Pharmaceuticals Holding. Walvax Biotechnology is listed as a regional player.

Does East Sunshine have an API?

No public API is recorded for East Sunshine.

What industry is East Sunshine in?

East Sunshine's product category is Diversified Industrial Manufacturing (Electronic Materials, Pharmaceuticals, Health Products). Its primary akta.pro industry code is IMAEAAAC, Chlor-Alkali & Derivatives, with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 42421 and its SIC code is 2800.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals